<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9036064</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">35478700</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9036064</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fnagi.2022.773119</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>TABLE 1</table-label><table-caption>Demographic, clinical, and cognitive variables.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>TABLE 1</label><caption><p>Demographic, clinical, and cognitive variables.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Variable</td><td valign="top" align="left" rowspan="1" colspan="1">SCA3 (<italic>n</italic> = 41)</td><td valign="top" align="left" rowspan="1" colspan="1">HCs (<italic>n</italic> = 41)</td><td valign="top" align="left" rowspan="1" colspan="1">T/W/x<sup>2</sup> (<italic>p</italic> Value)</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender (M/F)</td><td valign="top" align="left" rowspan="1" colspan="1">23/18</td><td valign="top" align="left" rowspan="1" colspan="1">24/17</td><td valign="top" align="left" rowspan="1" colspan="1">2.49(0.35<sup><italic>b</italic></sup>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="left" rowspan="1" colspan="1">17–67 (40.51 ± 12.13)</td><td valign="top" align="left" rowspan="1" colspan="1">21–64 (40.10 ± 11.56)</td><td valign="top" align="left" rowspan="1" colspan="1">−0.23(0.82<sup><italic>a</italic></sup>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Onset age (years)</td><td valign="top" align="left" rowspan="1" colspan="1">18–58 (35.25 ± 10.67)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disease duration</td><td valign="top" align="left" rowspan="1" colspan="1">0–21 (6.76 ± 4.98)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CAG repeats</td><td valign="top" align="left" rowspan="1" colspan="1">57–72 (65.71 ± 3.57)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SARA</td><td valign="top" align="left" rowspan="1" colspan="1">0–33 (10.62 ± 8.54)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS</td><td valign="top" align="left" rowspan="1" colspan="1">0–73 (27.33 ± 19.43)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS—posture and gait disturbances</td><td valign="top" align="left" rowspan="1" colspan="1">0–34 (12.78 ± 9.34)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS—kinetic functions</td><td valign="top" align="left" rowspan="1" colspan="1">0–50 (12.76 ± 10.40)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS—dysarthria</td><td valign="top" align="left" rowspan="1" colspan="1">0–8 (1.71 ± 2.00)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS—oculomotor disorders</td><td valign="top" align="left" rowspan="1" colspan="1">0–6 (1.80 ± 1.79)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HMAD</td><td valign="top" align="left" rowspan="1" colspan="1">0–32 (7.157 ± 6.898)</td><td valign="top" align="left" rowspan="1" colspan="1">0–17 (1.73 ± 3.39)</td><td valign="top" align="left" rowspan="1" colspan="1">−4.52(0.00<sup>***<italic>a</italic></sup>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MoCA</td><td valign="top" align="left" rowspan="1" colspan="1">10–30 (22.95 ± 4.96)</td><td valign="top" align="left" rowspan="1" colspan="1">19–30 (27.37 ± 2.93)</td><td valign="top" align="left" rowspan="1" colspan="1">4.91(0.00<sup>***<italic>a</italic></sup>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RVR</td><td valign="top" align="left" rowspan="1" colspan="1">16–72 (36.53 ± 10.93)</td><td valign="top" align="left" rowspan="1" colspan="1">32–80 (50.83 ± 11.51)</td><td valign="top" align="left" rowspan="1" colspan="1">5.77(0.00<sup>***<italic>a</italic></sup>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DS</td><td valign="top" align="left" rowspan="1" colspan="1">3–13 (8.72 ± 2.13)</td><td valign="top" align="left" rowspan="1" colspan="1">5–16 (9.51 ± 2.16)</td><td valign="top" align="left" rowspan="1" colspan="1">1.68(0.10<sup><italic>a</italic></sup>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ADL+IADL</td><td valign="top" align="left" rowspan="1" colspan="1">20–66 (28.39 ± 12.94)</td><td valign="top" align="left" rowspan="1" colspan="1">20–21 (20.02 ± 0.16)</td><td valign="top" align="left" rowspan="1" colspan="1">−5.97(0.00<sup>***<italic>c</italic></sup>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MMSE</td><td valign="top" align="left" rowspan="1" colspan="1">13–30 (27.28 ± 3.47)</td><td valign="top" align="left" rowspan="1" colspan="1">22–30 (28.81 ± 1.81)</td><td valign="top" align="left" rowspan="1" colspan="1">2.60(0.01<sup>**<italic>c</italic></sup>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><p><italic>Values are presented as a range (mean ± standard deviation).</italic></p></fn><fn id="tfn2"><p><italic>Onset age, age at onset of ataxia symptoms; Duration: Duration between onset and examination age; SARA, Scale for the Assessment and Rating of Ataxia; ICARS, International Cooperative Ataxia Rating Scale; ADL, Activities of Daily Living; IADL, Instrumental Activities of Daily Living; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; RVR, rapid verbal retrieval; DS, Digit Span; HAMD, Hamilton Rating Scale for Depression; M/F, Males/Females.</italic></p></fn><fn id="tfn3"><p><italic>**, P &lt; 0.01.</italic></p></fn><fn id="tfn4"><p><italic>***, P &lt; 0.001.</italic></p></fn><fn id="tfn5"><p><italic>a, Two-sample two-tailed t test.</italic></p></fn><fn id="tfn6"><p><italic>b, Two-tailed Pearson chi-square test.</italic></p></fn><fn id="tfn7"><p><italic>c, Mann–Whitney U-test.</italic></p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic, clinical, and cognitive variables.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left">Variable</td><td valign="top" align="left">SCA3 (n = 41)</td><td valign="top" align="left">HCs (n = 41)</td><td valign="top" align="left">T/W/x2 (p Value)</td></tr></thead><tbody><tr><td valign="top" align="left">Gender (M/F)</td><td valign="top" align="left">23/18</td><td valign="top" align="left">24/17</td><td valign="top" align="left">2.49(0.35b)</td></tr><tr><td valign="top" align="left">Age (years)</td><td valign="top" align="left">17–67 (40.51 ± 12.13)</td><td valign="top" align="left">21–64 (40.10 ± 11.56)</td><td valign="top" align="left">−0.23(0.82a)</td></tr><tr><td valign="top" align="left">Onset age (years)</td><td valign="top" align="left">18–58 (35.25 ± 10.67)</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">Disease duration</td><td valign="top" align="left">0–21 (6.76 ± 4.98)</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">CAG repeats</td><td valign="top" align="left">57–72 (65.71 ± 3.57)</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">SARA</td><td valign="top" align="left">0–33 (10.62 ± 8.54)</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">ICARS</td><td valign="top" align="left">0–73 (27.33 ± 19.43)</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">ICARS—posture and gait disturbances</td><td valign="top" align="left">0–34 (12.78 ± 9.34)</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">ICARS—kinetic functions</td><td valign="top" align="left">0–50 (12.76 ± 10.40)</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">ICARS—dysarthria</td><td valign="top" align="left">0–8 (1.71 ± 2.00)</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">ICARS—oculomotor disorders</td><td valign="top" align="left">0–6 (1.80 ± 1.79)</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">HMAD</td><td valign="top" align="left">0–32 (7.157 ± 6.898)</td><td valign="top" align="left">0–17 (1.73 ± 3.39)</td><td valign="top" align="left">−4.52(0.00***a)</td></tr><tr><td valign="top" align="left">MoCA</td><td valign="top" align="left">10–30 (22.95 ± 4.96)</td><td valign="top" align="left">19–30 (27.37 ± 2.93)</td><td valign="top" align="left">4.91(0.00***a)</td></tr><tr><td valign="top" align="left">RVR</td><td valign="top" align="left">16–72 (36.53 ± 10.93)</td><td valign="top" align="left">32–80 (50.83 ± 11.51)</td><td valign="top" align="left">5.77(0.00***a)</td></tr><tr><td valign="top" align="left">DS</td><td valign="top" align="left">3–13 (8.72 ± 2.13)</td><td valign="top" align="left">5–16 (9.51 ± 2.16)</td><td valign="top" align="left">1.68(0.10a)</td></tr><tr><td valign="top" align="left">ADL+IADL</td><td valign="top" align="left">20–66 (28.39 ± 12.94)</td><td valign="top" align="left">20–21 (20.02 ± 0.16)</td><td valign="top" align="left">−5.97(0.00***c)</td></tr><tr><td valign="top" align="left">MMSE</td><td valign="top" align="left">13–30 (27.28 ± 3.47)</td><td valign="top" align="left">22–30 (28.81 ± 1.81)</td><td valign="top" align="left">2.60(0.01**c)</td></tr></tbody></table></div>Values are presented as a range (mean ± standard deviation).Onset age, age at onset of ataxia symptoms; Duration: Duration between onset and examination age; SARA, Scale for the Assessment and Rating of Ataxia; ICARS, International Cooperative Ataxia Rating Scale; ADL, Activities of Daily Living; IADL, Instrumental Activities of Daily Living; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; RVR, rapid verbal retrieval; DS, Digit Span; HAMD, Hamilton Rating Scale for Depression; M/F, Males/Females.**, P &lt; 0.01.***, P &lt; 0.001.a, Two-sample two-tailed t test.b, Two-tailed Pearson chi-square test.c, Mann–Whitney U-test.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>TABLE 2</table-label><table-caption>Correlations between global neuroimaging attributions and clinical variables.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T2"><label>TABLE 2</label><caption><p>Correlations between global neuroimaging attributions and clinical variables.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Variable</td><td valign="top" align="left" rowspan="1" colspan="1">σ</td><td valign="top" align="left" rowspan="1" colspan="1">C<sub>P</sub></td><td valign="top" align="left" rowspan="1" colspan="1">γ</td><td valign="top" align="left" rowspan="1" colspan="1">E<sub>l<italic>oc</italic></sub></td><td valign="top" align="left" rowspan="1" colspan="1">Modularity</td><td valign="top" align="left" rowspan="1" colspan="1">λ</td><td valign="top" align="left" rowspan="1" colspan="1">L<sub>P</sub></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Onset age (years) (P)</td><td valign="top" align="left" rowspan="1" colspan="1">−0.16 (<italic>0.44</italic>)<break/> [−0.47, 0.18]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.03 (<italic>0.84</italic>)<break/> [−0.36, 0.30]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.15 (<italic>0.48</italic>)<break/> [−0.46, 0.19]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.03 (<italic>0.87</italic>)<break/> [−0.35, 0.30]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.17 (<italic>0.40</italic>)<break/> [−0.47, 0.17]</td><td valign="top" align="left" rowspan="1" colspan="1">0.03 (<italic>0.85</italic>)<break/> [−0.30, 0.36]</td><td valign="top" align="left" rowspan="1" colspan="1">0.03 (<italic>0.92</italic>)<break/> [−0.31, 0.35]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Disease duration (P)</td><td valign="top" align="left" rowspan="1" colspan="1">0.16 (<italic>0.44</italic>)<break/> [−0.18, 0.47]</td><td valign="top" align="left" rowspan="1" colspan="1">0.03 (<italic>0.84</italic>)<break/> [−0.30, 0.36]</td><td valign="top" align="left" rowspan="1" colspan="1">0.15 (<italic>0.48</italic>)<break/> [−0.19, 0.46]</td><td valign="top" align="left" rowspan="1" colspan="1">0.03 (<italic>0.87</italic>)<break/> [−0.30, 0.35]</td><td valign="top" align="left" rowspan="1" colspan="1">0.17 (<italic>0.40</italic>)<break/> [−0.17, 0.47]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.03 (<italic>0.85</italic>)<break/> [−0.36, 0.30]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.03 (<italic>0.92</italic>)<break/> [−0.35, 0.31]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CAG repeats (P)</td><td valign="top" align="left" rowspan="1" colspan="1">0.24 (<italic>0.23</italic>)<break/> [−0.09, 0.53]</td><td valign="top" align="left" rowspan="1" colspan="1">0.14 (<italic>0.59</italic>)<break/> [−0.19, 0.45]</td><td valign="top" align="left" rowspan="1" colspan="1">0.24 (<italic>0.23</italic>)<break/> [−0.09, 0.53]</td><td valign="top" align="left" rowspan="1" colspan="1">0.14 (<italic>0.59</italic>)<break/> [−0.20, 0.45]</td><td valign="top" align="left" rowspan="1" colspan="1">0.25 (<italic>0.27</italic>)<break/> [−0.09, 0.53]</td><td valign="top" align="left" rowspan="1" colspan="1">0.10 (<italic>0.69</italic>)<break/> [−0.24, 0.42]</td><td valign="top" align="left" rowspan="1" colspan="1">0.11 (<italic>0.65</italic>)<break/> [−0.23, 0.42]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SARA (P)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.44 (<italic>0.03</italic>) * [0.13, 0.67]</bold></td><td valign="top" align="left" rowspan="1" colspan="1">0.29 (<italic>0.25</italic>) [−0.05, 0.56]</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.44 (<italic>0.03</italic>) * [0.16, 0.67]</bold></td><td valign="top" align="left" rowspan="1" colspan="1">0.29 (<italic>0.24</italic>) [−0.04, 0.56]</td><td valign="top" align="left" rowspan="1" colspan="1">0.35 (<italic>0.14</italic>) [0.02, 0.61]</td><td valign="top" align="left" rowspan="1" colspan="1">0.22 (<italic>0.55</italic>) [−0.11, 0.52]</td><td valign="top" align="left" rowspan="1" colspan="1">0.22 (<italic>0.53</italic>) [−0.11, 0.52]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS (P)</td><td valign="top" align="left" rowspan="1" colspan="1">0.35 (<italic>0.08</italic>) [0.04, 0.62]</td><td valign="top" align="left" rowspan="1" colspan="1">0.28 (<italic>0.25</italic>) [−0.05, 0.56]</td><td valign="top" align="left" rowspan="1" colspan="1">0.36 (<italic>0.07</italic>) [0.04, 0.62]</td><td valign="top" align="left" rowspan="1" colspan="1">0.28 (<italic>0.24</italic>) [−0.05, 0.56]</td><td valign="top" align="left" rowspan="1" colspan="1">0.30 (<italic>0.19</italic>) [−0.03, 0.57]</td><td valign="top" align="left" rowspan="1" colspan="1">0.22 (<italic>0.55</italic>) [−0.11, 0.52]</td><td valign="top" align="left" rowspan="1" colspan="1">0.22 (<italic>0.53</italic>) [−0.11, 0.52]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS—posture and gait disturbances (P)</td><td valign="top" align="left" rowspan="1" colspan="1">0.36 (<italic>0.08</italic>) [0.04, 0.62]</td><td valign="top" align="left" rowspan="1" colspan="1">0.29 (<italic>0.25</italic>) [−0.04, 0.57]</td><td valign="top" align="left" rowspan="1" colspan="1">0.36 (<italic>0.07</italic>) [0.04, 0.62]</td><td valign="top" align="left" rowspan="1" colspan="1">0.29 (<italic>0.25</italic>) [−0.04, 0.57]</td><td valign="top" align="left" rowspan="1" colspan="1">0.33 (<italic>0.17</italic>) [−0.003, 0.59]</td><td valign="top" align="left" rowspan="1" colspan="1">0.23 (<italic>0.55</italic>) [−0.11, 0.52]</td><td valign="top" align="left" rowspan="1" colspan="1">0.22 (<italic>0.53</italic>) [−0.11, 0.52]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS—kinetic functions (P)</td><td valign="top" align="left" rowspan="1" colspan="1">0.32 (<italic>0.12</italic>) [−0.01, 0.59]</td><td valign="top" align="left" rowspan="1" colspan="1">0.25 (<italic>0.34</italic>) [−0.09, 0.53]</td><td valign="top" align="left" rowspan="1" colspan="1">0.32 (<italic>0.12</italic>) [−0.01, 0.59]</td><td valign="top" align="left" rowspan="1" colspan="1">0.25 (<italic>0.31</italic>) [−0.09, 0.53]</td><td valign="top" align="left" rowspan="1" colspan="1">0.27 (<italic>0.23</italic>) [−0.07, 0.55]</td><td valign="top" align="left" rowspan="1" colspan="1">0.18 (<italic>0.55</italic>) [−0.16, 0.48]</td><td valign="top" align="left" rowspan="1" colspan="1">0.18 (<italic>0.53</italic>) [−0.15, 0.48]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS—dysarthria (P)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.41 (<italic>0.04</italic>) * [0.10, 0.65]</bold></td><td valign="top" align="left" rowspan="1" colspan="1">0.29 (<italic>0.25</italic>) [−0.05, 0.56]</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.42 (<italic>0.04</italic>) * [0.10, 0.66]</bold></td><td valign="top" align="left" rowspan="1" colspan="1">0.29 (<italic>0.25</italic>) [−0.04, 0.56]</td><td valign="top" align="left" rowspan="1" colspan="1">0.28 (<italic>0.23</italic>) [−0.05, 0.55]</td><td valign="top" align="left" rowspan="1" colspan="1">0.25 (<italic>0.55</italic>) [−0.08, 0.54]</td><td valign="top" align="left" rowspan="1" colspan="1">0.25 (<italic>0.53</italic>) [−0.09, 0.53]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS—oculomotor disorders (S)</td><td valign="top" align="left" rowspan="1" colspan="1">0.23 (<italic>0.23</italic>) [−0.09, 0.53]</td><td valign="top" align="left" rowspan="1" colspan="1">0.08 (<italic>0.73</italic>) [−0.25, 0.40]</td><td valign="top" align="left" rowspan="1" colspan="1">0.23 (<italic>0.18</italic>) [−0.08, 0.53]</td><td valign="top" align="left" rowspan="1" colspan="1">0.10 (<italic>0.65</italic>) [−0.24, 0.41]</td><td valign="top" align="left" rowspan="1" colspan="1">0.19 (<italic>0.36</italic>) [−0.14, 0.50]</td><td valign="top" align="left" rowspan="1" colspan="1">0.06 (<italic>0.82</italic>) [−0.27, 0.38]</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (<italic>0.93</italic>) [−0.31, 0.34]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">HMAD (P)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.44 (<italic>0.03</italic>) * [0.14, 0.68]</bold></td><td valign="top" align="left" rowspan="1" colspan="1">0.35 (<italic>0.25</italic>) [0.02, 0.61]</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.44 (<italic>0.03</italic>) * [0.13, 0.67]</bold></td><td valign="top" align="left" rowspan="1" colspan="1">0.35 (<italic>0.24</italic>) [0.02, 0.61]</td><td valign="top" align="left" rowspan="1" colspan="1">0.40 (<italic>0.08</italic>) [0.08, 0.64]</td><td valign="top" align="left" rowspan="1" colspan="1">0.18 (<italic>0.55</italic>) [−0.16, 0.48]</td><td valign="top" align="left" rowspan="1" colspan="1">0.18 (<italic>0.53</italic>) [−0.15, 0.48]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ADL+IADL (S)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.63 (<italic>0.00</italic>) ** [0.38, 0.79]</bold></td><td valign="top" align="left" rowspan="1" colspan="1">0.30 (<italic>0.25</italic>) [−0.02, 0.57]</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.44 (<italic>0.01</italic>) ** [0.37, 0.79]</bold></td><td valign="top" align="left" rowspan="1" colspan="1">0.31 (<italic>0.25</italic>) [−0.02, 0.58]</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.57 (<italic>0.01</italic>) ** [0.30, 0.76]</bold></td><td valign="top" align="left" rowspan="1" colspan="1">0.24 (<italic>0.55</italic>) [−0.10, 0.53]</td><td valign="top" align="left" rowspan="1" colspan="1">0.21 (<italic>0.53</italic>) [−0.13, 0.50]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MMSE (S)</td><td valign="top" align="left" rowspan="1" colspan="1">−0.28 (<italic>0.18</italic>) [−0.56, 0.05]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.21 (<italic>0.38</italic>) [−0.51, 0.12]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.25 (<italic>0.15</italic>) [−0.55, 0.07]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.24 (<italic>0.32</italic>) [−0.53, 0.09]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.23 (<italic>0.28</italic>) [−0.52, 0.10]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.22 (<italic>0.55</italic>) [−0.51, 0.11]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.22 (<italic>0.53</italic>) [−0.52, 0.11]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MoCA (P)</td><td valign="top" align="left" rowspan="1" colspan="1">−0.12 (<italic>0.52</italic>) [−0.43, 0.21]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.13 (<italic>0.62</italic>) [−0.44, 0.21]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.13 (<italic>0.49</italic>) [−0.44, 0.21]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.13 (<italic>0.62</italic>) [−0.44, 0.21]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.11 (<italic>0.56</italic>) [−0.42, 0.23]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.16 (<italic>0.55</italic>) [−0.47, 0.18]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.17 (<italic>0.53</italic>) [−0.47, 0.17]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RVR (P)</td><td valign="top" align="left" rowspan="1" colspan="1">−0.09 (<italic>0.62</italic>) [−0.4, 0.24]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.11 (<italic>0.63</italic>) [−0.43, 0.22]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.09 (<italic>0.59</italic>) [−0.41, 0.24]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.11 (<italic>0.63</italic>) [−0.43, 0.22]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.08 (<italic>0.66</italic>) [−0.40, 0.26]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.11 (<italic>0.69</italic>) [−0.42, 0.23]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.12 (<italic>0.65</italic>) [−0.43, 0.22]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DS (P)</td><td valign="top" align="left" rowspan="1" colspan="1">−0.13 (<italic>0.52</italic>) [−0.44, 0.21]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.21 (<italic>0.38</italic>) [−0.51, 0.12]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.14 (<italic>0.49</italic>) [−0.45, 0.20]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.22 (<italic>0.35</italic>) [−0.51, 0.11]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.12 (<italic>0.54</italic>) [−0.44, 0.21]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.21 (<italic>0.55</italic>) [−0.50, 0.13]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.20 (<italic>0.53</italic>) [−0.50, 0.14]</td></tr></tbody></table><table-wrap-foot><fn id="tfn8"><p><italic>The values are presented as correlation coefficients with r (P<sub>FDR</sub>) [95% confidence interval].</italic></p></fn><fn id="tfn9"><p><italic>Onset age, age at onset of ataxia symptoms; Duration, Duration between onset and examination age; SARA, Scale for the assessment and rating of ataxia; ICARS, International Cooperative Ataxia Rating Scale; ADL, Activities of Daily Living; IADL, Instrumental Activities of Daily Living; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; RVR, rapid verbal retrieval; DS, Digit Span; HAMD, Hamilton Rating Scale for Depression; σ, small-worldness; γ, Normalized clustering coefficient.</italic></p></fn><fn id="tfn10"><p><italic>*, P<sub>FDR</sub> ≤ 0.05; **, P<sub>FDR</sub> ≤ 0.01.</italic></p></fn><fn id="tfn11"><p><italic>P, Pearson correlation.</italic></p></fn><fn id="tfn12"><p><italic>S, Spearman rank correlation. The meaning of the bold values is to make the significant results more obvious to readers.</italic></p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Correlations between global neuroimaging attributions and clinical variables.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left">Variable</td><td valign="top" align="left">σ</td><td valign="top" align="left">CP</td><td valign="top" align="left">γ</td><td valign="top" align="left">Eloc</td><td valign="top" align="left">Modularity</td><td valign="top" align="left">λ</td><td valign="top" align="left">LP</td></tr></thead><tbody><tr><td valign="top" align="left">Onset age (years) (P)</td><td valign="top" align="left">−0.16 (0.44) [−0.47, 0.18]</td><td valign="top" align="left">−0.03 (0.84) [−0.36, 0.30]</td><td valign="top" align="left">−0.15 (0.48) [−0.46, 0.19]</td><td valign="top" align="left">−0.03 (0.87) [−0.35, 0.30]</td><td valign="top" align="left">−0.17 (0.40) [−0.47, 0.17]</td><td valign="top" align="left">0.03 (0.85) [−0.30, 0.36]</td><td valign="top" align="left">0.03 (0.92) [−0.31, 0.35]</td></tr><tr><td valign="top" align="left">Disease duration (P)</td><td valign="top" align="left">0.16 (0.44) [−0.18, 0.47]</td><td valign="top" align="left">0.03 (0.84) [−0.30, 0.36]</td><td valign="top" align="left">0.15 (0.48) [−0.19, 0.46]</td><td valign="top" align="left">0.03 (0.87) [−0.30, 0.35]</td><td valign="top" align="left">0.17 (0.40) [−0.17, 0.47]</td><td valign="top" align="left">−0.03 (0.85) [−0.36, 0.30]</td><td valign="top" align="left">−0.03 (0.92) [−0.35, 0.31]</td></tr><tr><td valign="top" align="left">CAG repeats (P)</td><td valign="top" align="left">0.24 (0.23) [−0.09, 0.53]</td><td valign="top" align="left">0.14 (0.59) [−0.19, 0.45]</td><td valign="top" align="left">0.24 (0.23) [−0.09, 0.53]</td><td valign="top" align="left">0.14 (0.59) [−0.20, 0.45]</td><td valign="top" align="left">0.25 (0.27) [−0.09, 0.53]</td><td valign="top" align="left">0.10 (0.69) [−0.24, 0.42]</td><td valign="top" align="left">0.11 (0.65) [−0.23, 0.42]</td></tr><tr><td valign="top" align="left">SARA (P)</td><td valign="top" align="left">0.44 (0.03) * [0.13, 0.67]</td><td valign="top" align="left">0.29 (0.25) [−0.05, 0.56]</td><td valign="top" align="left">0.44 (0.03) * [0.16, 0.67]</td><td valign="top" align="left">0.29 (0.24) [−0.04, 0.56]</td><td valign="top" align="left">0.35 (0.14) [0.02, 0.61]</td><td valign="top" align="left">0.22 (0.55) [−0.11, 0.52]</td><td valign="top" align="left">0.22 (0.53) [−0.11, 0.52]</td></tr><tr><td valign="top" align="left">ICARS (P)</td><td valign="top" align="left">0.35 (0.08) [0.04, 0.62]</td><td valign="top" align="left">0.28 (0.25) [−0.05, 0.56]</td><td valign="top" align="left">0.36 (0.07) [0.04, 0.62]</td><td valign="top" align="left">0.28 (0.24) [−0.05, 0.56]</td><td valign="top" align="left">0.30 (0.19) [−0.03, 0.57]</td><td valign="top" align="left">0.22 (0.55) [−0.11, 0.52]</td><td valign="top" align="left">0.22 (0.53) [−0.11, 0.52]</td></tr><tr><td valign="top" align="left">ICARS—posture and gait disturbances (P)</td><td valign="top" align="left">0.36 (0.08) [0.04, 0.62]</td><td valign="top" align="left">0.29 (0.25) [−0.04, 0.57]</td><td valign="top" align="left">0.36 (0.07) [0.04, 0.62]</td><td valign="top" align="left">0.29 (0.25) [−0.04, 0.57]</td><td valign="top" align="left">0.33 (0.17) [−0.003, 0.59]</td><td valign="top" align="left">0.23 (0.55) [−0.11, 0.52]</td><td valign="top" align="left">0.22 (0.53) [−0.11, 0.52]</td></tr><tr><td valign="top" align="left">ICARS—kinetic functions (P)</td><td valign="top" align="left">0.32 (0.12) [−0.01, 0.59]</td><td valign="top" align="left">0.25 (0.34) [−0.09, 0.53]</td><td valign="top" align="left">0.32 (0.12) [−0.01, 0.59]</td><td valign="top" align="left">0.25 (0.31) [−0.09, 0.53]</td><td valign="top" align="left">0.27 (0.23) [−0.07, 0.55]</td><td valign="top" align="left">0.18 (0.55) [−0.16, 0.48]</td><td valign="top" align="left">0.18 (0.53) [−0.15, 0.48]</td></tr><tr><td valign="top" align="left">ICARS—dysarthria (P)</td><td valign="top" align="left">0.41 (0.04) * [0.10, 0.65]</td><td valign="top" align="left">0.29 (0.25) [−0.05, 0.56]</td><td valign="top" align="left">0.42 (0.04) * [0.10, 0.66]</td><td valign="top" align="left">0.29 (0.25) [−0.04, 0.56]</td><td valign="top" align="left">0.28 (0.23) [−0.05, 0.55]</td><td valign="top" align="left">0.25 (0.55) [−0.08, 0.54]</td><td valign="top" align="left">0.25 (0.53) [−0.09, 0.53]</td></tr><tr><td valign="top" align="left">ICARS—oculomotor disorders (S)</td><td valign="top" align="left">0.23 (0.23) [−0.09, 0.53]</td><td valign="top" align="left">0.08 (0.73) [−0.25, 0.40]</td><td valign="top" align="left">0.23 (0.18) [−0.08, 0.53]</td><td valign="top" align="left">0.10 (0.65) [−0.24, 0.41]</td><td valign="top" align="left">0.19 (0.36) [−0.14, 0.50]</td><td valign="top" align="left">0.06 (0.82) [−0.27, 0.38]</td><td valign="top" align="left">0.02 (0.93) [−0.31, 0.34]</td></tr><tr><td valign="top" align="left">HMAD (P)</td><td valign="top" align="left">0.44 (0.03) * [0.14, 0.68]</td><td valign="top" align="left">0.35 (0.25) [0.02, 0.61]</td><td valign="top" align="left">0.44 (0.03) * [0.13, 0.67]</td><td valign="top" align="left">0.35 (0.24) [0.02, 0.61]</td><td valign="top" align="left">0.40 (0.08) [0.08, 0.64]</td><td valign="top" align="left">0.18 (0.55) [−0.16, 0.48]</td><td valign="top" align="left">0.18 (0.53) [−0.15, 0.48]</td></tr><tr><td valign="top" align="left">ADL+IADL (S)</td><td valign="top" align="left">0.63 (0.00) ** [0.38, 0.79]</td><td valign="top" align="left">0.30 (0.25) [−0.02, 0.57]</td><td valign="top" align="left">0.44 (0.01) ** [0.37, 0.79]</td><td valign="top" align="left">0.31 (0.25) [−0.02, 0.58]</td><td valign="top" align="left">0.57 (0.01) ** [0.30, 0.76]</td><td valign="top" align="left">0.24 (0.55) [−0.10, 0.53]</td><td valign="top" align="left">0.21 (0.53) [−0.13, 0.50]</td></tr><tr><td valign="top" align="left">MMSE (S)</td><td valign="top" align="left">−0.28 (0.18) [−0.56, 0.05]</td><td valign="top" align="left">−0.21 (0.38) [−0.51, 0.12]</td><td valign="top" align="left">−0.25 (0.15) [−0.55, 0.07]</td><td valign="top" align="left">−0.24 (0.32) [−0.53, 0.09]</td><td valign="top" align="left">−0.23 (0.28) [−0.52, 0.10]</td><td valign="top" align="left">−0.22 (0.55) [−0.51, 0.11]</td><td valign="top" align="left">−0.22 (0.53) [−0.52, 0.11]</td></tr><tr><td valign="top" align="left">MoCA (P)</td><td valign="top" align="left">−0.12 (0.52) [−0.43, 0.21]</td><td valign="top" align="left">−0.13 (0.62) [−0.44, 0.21]</td><td valign="top" align="left">−0.13 (0.49) [−0.44, 0.21]</td><td valign="top" align="left">−0.13 (0.62) [−0.44, 0.21]</td><td valign="top" align="left">−0.11 (0.56) [−0.42, 0.23]</td><td valign="top" align="left">−0.16 (0.55) [−0.47, 0.18]</td><td valign="top" align="left">−0.17 (0.53) [−0.47, 0.17]</td></tr><tr><td valign="top" align="left">RVR (P)</td><td valign="top" align="left">−0.09 (0.62) [−0.4, 0.24]</td><td valign="top" align="left">−0.11 (0.63) [−0.43, 0.22]</td><td valign="top" align="left">−0.09 (0.59) [−0.41, 0.24]</td><td valign="top" align="left">−0.11 (0.63) [−0.43, 0.22]</td><td valign="top" align="left">−0.08 (0.66) [−0.40, 0.26]</td><td valign="top" align="left">−0.11 (0.69) [−0.42, 0.23]</td><td valign="top" align="left">−0.12 (0.65) [−0.43, 0.22]</td></tr><tr><td valign="top" align="left">DS (P)</td><td valign="top" align="left">−0.13 (0.52) [−0.44, 0.21]</td><td valign="top" align="left">−0.21 (0.38) [−0.51, 0.12]</td><td valign="top" align="left">−0.14 (0.49) [−0.45, 0.20]</td><td valign="top" align="left">−0.22 (0.35) [−0.51, 0.11]</td><td valign="top" align="left">−0.12 (0.54) [−0.44, 0.21]</td><td valign="top" align="left">−0.21 (0.55) [−0.50, 0.13]</td><td valign="top" align="left">−0.20 (0.53) [−0.50, 0.14]</td></tr></tbody></table></div>The values are presented as correlation coefficients with r (PFDR) [95% confidence interval].Onset age, age at onset of ataxia symptoms; Duration, Duration between onset and examination age; SARA, Scale for the assessment and rating of ataxia; ICARS, International Cooperative Ataxia Rating Scale; ADL, Activities of Daily Living; IADL, Instrumental Activities of Daily Living; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; RVR, rapid verbal retrieval; DS, Digit Span; HAMD, Hamilton Rating Scale for Depression; σ, small-worldness; γ, Normalized clustering coefficient.*, PFDR ≤ 0.05; **, PFDR ≤ 0.01.P, Pearson correlation.S, Spearman rank correlation. The meaning of the bold values is to make the significant results more obvious to readers.</transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>TABLE 3</table-label><table-caption>Correlations between regional neuroimaging attributions and clinical variables.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T3"><label>TABLE 3</label><caption><p>Correlations between regional neuroimaging attributions and clinical variables.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1">Variable</td><td valign="top" align="center" colspan="2" rowspan="1">Left cuneus<hr/></td><td valign="top" align="center" colspan="2" rowspan="1">Right cuneus<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Cp</td><td valign="top" align="left" rowspan="1" colspan="1">Eloc</td><td valign="top" align="left" rowspan="1" colspan="1">Cp</td><td valign="top" align="left" rowspan="1" colspan="1">Eloc</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">ICARS-Dysarthria (P)</td><td valign="top" align="left" rowspan="1" colspan="1">−<bold>0.42 <italic>(0.03)</italic> *</bold> [−0.66, −0.11]</td><td valign="top" align="left" rowspan="1" colspan="1">−<bold>0.41 <italic>(0.05)</italic> *</bold> [−0.65, −0.10]</td><td valign="top" align="left" rowspan="1" colspan="1">−<bold>0.43 <italic>(0.03)</italic> *</bold> [−0.67, −0.12]</td><td valign="top" align="left" rowspan="1" colspan="1">−<bold>0.43 <italic>(0.05)</italic> *</bold> [−0.66, −0.11]</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ADL+IADL (S)</td><td valign="top" align="left" rowspan="1" colspan="1">−<bold>0.48 <italic>(0.02)</italic> *</bold> [−0.70, −0.17]</td><td valign="top" align="left" rowspan="1" colspan="1">−<bold>0.49 <italic>(0.02)</italic> *</bold> [−0.70, −0.19]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.26 <italic>(0.34)</italic> [−0.54, 0.07]</td><td valign="top" align="left" rowspan="1" colspan="1">−0.25 <italic>(0.39)</italic> [−0.54, 0.08]</td></tr></tbody></table><table-wrap-foot><fn id="tfn13"><p><italic>The values are presented as correlation coefficients with r (P<sub>FDR</sub>) [95% confidence interval].</italic></p></fn><fn id="tfn14"><p><italic>ICARS, International Cooperative Ataxia Rating Scale; ADL, Activities of daily living; IADL, Instrumental Activities of Daily Living; Cp, Clustering coefficient; Eloc, Local efficiency; *, P<sub>FDR</sub> ≤ 0.05.</italic></p></fn><fn id="tfn15"><p><italic>(P), Pearson correlation.</italic></p></fn><fn id="tfn16"><p><italic>(S), Spearman rank correlation. The meaning of the bold values is to make the significant results more obvious to readers.</italic></p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>TABLE 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Correlations between regional neuroimaging attributions and clinical variables.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left">Variable</td><td valign="top" align="center" colspan="2">Left cuneus</td><td valign="top" align="center" colspan="2">Right cuneus</td></tr><tr><td valign="top" align="left"/><td valign="top" align="left">Cp</td><td valign="top" align="left">Eloc</td><td valign="top" align="left">Cp</td><td valign="top" align="left">Eloc</td></tr></thead><tbody><tr><td valign="top" align="left">ICARS-Dysarthria (P)</td><td valign="top" align="left">−0.42 (0.03) * [−0.66, −0.11]</td><td valign="top" align="left">−0.41 (0.05) * [−0.65, −0.10]</td><td valign="top" align="left">−0.43 (0.03) * [−0.67, −0.12]</td><td valign="top" align="left">−0.43 (0.05) * [−0.66, −0.11]</td></tr><tr><td valign="top" align="left">ADL+IADL (S)</td><td valign="top" align="left">−0.48 (0.02) * [−0.70, −0.17]</td><td valign="top" align="left">−0.49 (0.02) * [−0.70, −0.19]</td><td valign="top" align="left">−0.26 (0.34) [−0.54, 0.07]</td><td valign="top" align="left">−0.25 (0.39) [−0.54, 0.08]</td></tr></tbody></table></div>The values are presented as correlation coefficients with r (PFDR) [95% confidence interval].ICARS, International Cooperative Ataxia Rating Scale; ADL, Activities of daily living; IADL, Instrumental Activities of Daily Living; Cp, Clustering coefficient; Eloc, Local efficiency; *, PFDR ≤ 0.05.(P), Pearson correlation.(S), Spearman rank correlation. The meaning of the bold values is to make the significant results more obvious to readers.</transformed-table></extracted-table></extracted-tables-set>